Shellsea Portillo Canales, MD (she/her/hers)

ST LOUIS UNIVERSITY
Saint Louis, MO, United States

Disclosure information not submitted.

Presentation(s):

• SAT-801 - Cardiovascular Risk Associated with Romosozumab Treatment in Osteoporosis

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT